Insuman Implantable 400 IU/ml insulin solution for infusion: no new patients should be started due to discontinuation of MiniMed Implantable Pump
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Insuman
|
Active substance |
insulin human
|
Therapeutic area (MeSH) |
Diabetes Mellitus
|
DHPC type |
Type II variation
|
Human ATC code |
|
Dissemination date |
20/07/2020
|